4.4 Article

Elevated hypermutation levels in HIV-1 natural viral suppressors

Journal

VIROLOGY
Volume 443, Issue 2, Pages 306-312

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.virol.2013.05.019

Keywords

HIV-1; Natural viral suppressors (NVS); Hypermutation; Elite controllers

Categories

Funding

  1. Institute of Human Virology, University of Maryland School of Medicine, Baltimore
  2. NIH [1K23AI08-4580-01A1]

Ask authors/readers for more resources

Mutations in the HIV-1 proviral genomes delay the progression of the disease. We compared the mutation status in full-length proviral genomes of 23 HIV-infected patients with undetectable viral loads in the absence of therapy named natural viral suppressors (NVS) or Elite Controllers with 23 HIV-infected controls (10 patients on HAART treatment and 13 untreated patients). Provirus DNA was extracted from PBMC for amplification and sequencing to determine the mutation status. Nine (39 %) of the 23 NVS patients had defective proviral genomes, compared to 4 of the treated controls (40%, p = 0.96) and only one of the untreated controls (8%, p = 0.059). Most of the defective genomes resulted from Gto-A hypermutation. Among patients with hypermutation, the rate ratio for mutation was significantly higher for the NVS compared to treated controls (p = 0.043). Our data suggests that inactivation of the virus through the APOBEC3G system may contribute to the NVS phenotype. (C) 2013 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Food Science & Technology

Biologically active components in by-products of food processing

Yaseen Galali, Zagros A. Omar, S. Mohammad Sajadi

FOOD SCIENCE & NUTRITION (2020)

Letter Medicine, General & Internal

Binding and Neutralization Antibody Titers After a Single Vaccine Dose in Health Care Workers Previously Infected With SARS-CoV-2

Saman Saadat, Zahra Rikhtegaran Tehrani, James Logue, Michelle Newman, Matthew B. Frieman, Anthony D. Harris, Mohammad M. Sajadi

Summary: This study compared the titers of binding and neutralizing antibodies in healthcare workers previously infected with SARS-CoV-2 after receiving a single dose of mRNA coronavirus vaccine.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Multidisciplinary Sciences

Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study

Kathryn M. Hastie, Haoyang Li, Daniel Bedinger, Sharon L. Schendel, S. Moses Dennison, Kan Li, Vamseedhar Rayaprolu, Xiaoying Yu, Colin Mann, Michelle Zandonatti, Ruben Diaz Avalos, Dawid Zyla, Tierra Buck, Sean Hui, Kelly Shaffer, Chitra Hariharan, Jieyun Yin, Eduardo Olmedillas, Adrian Enriquez, Diptiben Parekh, Milite Abraha, Elizabeth Feeney, Gillian Q. Horn, Yoann Aldon, Hanif Ali, Sanja Aracic, Ronald R. Cobb, Ross S. Federman, Joseph M. Fernandez, Jacob Glanville, Robin Green, Gevorg Grigoryan, Ana G. Lujan Hernandez, David D. Ho, Kuan-Ying A. Huang, John Ingraham, Weidong Jiang, Paul Kellam, Cheolmin Kim, Minsoo Kim, Hyeong Mi Kim, Chao Kong, Shelly J. Krebs, Fei Lan, Guojun Lang, Sooyoung Lee, Cheuk Lun Leung, Junli Liu, Yanan Lu, Anna MacCamy, Andrew T. McGuire, Anne L. Palser, Terence H. Rabbitts, Zahra Rikhtegaran Tehrani, Mohammad M. Sajadi, Rogier W. Sanders, Aaron K. Sato, Liang Schweizer, Jimin Seo, Bingqing Shen, Jonne L. Snitselaar, Leonidas Stamatatos, Yongcong Tan, Milan T. Tomic, Marit J. van Gils, Sawsan Youssef, Jian Yu, Tom Z. Yuan, Qian Zhang, Bjoern Peters, Georgia D. Tomaras, Timothy Germann, Erica Ollmann Saphire

Summary: Antibody-based therapeutics and vaccines are crucial in combating COVID-19, especially with mutations and transmission of SARS-CoV-2. An international consortium identified multiple RBD-directed antibody communities, providing a framework for selecting treatment cocktails.

SCIENCE (2021)

Article Immunology

Safety and immunogenicity of an HIV-1 gp120-CD4 chimeric subunit vaccine in a phase 1a randomized controlled trial

Joel V. Chua, Charles Davis, Jennifer S. Husson, Amy Nelson, Ilia Prado, Robin Flinko, Ka Wing J. Lam, Lydiah Mutumbi, Bryan T. Mayer, Dan Dong, William Fulp, Celia Mahoney, Monica Gerber, Raphael Gottardo, Bruce L. Gilliam, Kelli Greene, Hongmei Gao, Nicole Yates, Guido Ferrari, Georgia Tomaras, David Montefiori, Jennifer A. Schwartz, Timothy Fouts, Anthony L. DeVico, George K. Lewis, Robert C. Gallo, Mohammad M. Sajadi

Summary: The IHV01 vaccine is a safe, well tolerated, and immunogenic FLSC vaccine construct capable of eliciting broadly reactive antibody responses against conserved CD4i epitopes, mediating antiviral functions.

VACCINE (2021)

Article Microbiology

Near-Pan-neutralizing, Plasma Deconvoluted Antibody N49P6 Mimics Host Receptor CD4 in Its Quaternary Interactions with the HIV-1 Envelope Trimer

William D. Tolbert, Dung N. Nguyen, Zahra Rikhtegaran Tehrani, Mohammad M. Sajadi, Marzena Pazgier

Summary: N49P6, a near-pan-neutralizing antibody targeting the CD4-binding site isolated from the plasma of an HIV-1 elite neutralizer, patient N49, exhibits exceptional neutralization breadth and potency due to its unique combination of CD4-binding site antibody characteristics along with interactions with the highly conserved gp120 inner domain. Furthermore, structural analysis of N49P6 in complex with the BG505 SOSIP trimer reveals that it achieves remarkable breadth by mimicking CD4's interaction with the neighboring gp120 protomer, representing a new class of CD4-binding site-specific broadly neutralizing antibodies.
Letter Medicine, General & Internal

SARS-CoV-2 vaccines for all but a single dose for COVID-19 survivors

Matthew Frieman, Anthony D. Harris, Ramin Sedaghat Herati, Florian Krammer, Alberto Mantovani, Maria Rescigno, Mohammad M. Sajadi, Viviana Simon

EBIOMEDICINE (2021)

Article Medicine, Research & Experimental

Combined cART including Tenofovir Disoproxil, Emtricitabine, and Dolutegravir has potent therapeutic effects in HIV-1 infected humanized mice

Matthew Weichseldorfer, Yvonne Affram, Alonso Heredia, Zahra Rikhtegaran-Tehrani, Mohammad M. Sajadi, Sumiko P. Williams, Yutaka Tagaya, Francesca Benedetti, Habib O. Ramadhani, Frank Denaro, Arshi Munawwar, Joseph Bryant, Davide Zella, Marvin Reitz, Fabio Romerio, Olga S. Latinovic

Summary: This study utilized a humanized mouse model with HIV-1 to analyze viral suppression and identify solid tissue reservoirs such as lymph nodes, brain, spleen, and liver. The findings suggest that these organs harbor residual infected cells, highlighting the importance of appropriate animal models for studying HIV-1 eradication efforts.

JOURNAL OF TRANSLATIONAL MEDICINE (2021)

Article Cell Biology

Role of miR-2392 in driving SARS-CoV-2 infection

J. Tyson McDonald, Francisco J. Enguita, Deanne Taylor, Robert J. Griffin, Waldemar Priebe, Mark R. Emmett, Mohammad M. Sajadi, Anthony D. Harris, Jean Clement, Joseph M. Dybas, Nukhet Aykin-Burns, Joseph W. Guarnieri, Larry N. Singh, Peter Grabham, Stephen B. Baylin, Aliza Yousey, Andrea N. Pearson, Peter M. Corry, Amanda Saravia-Butler, Thomas R. Aunins, Sadhana Sharma, Prashant Nagpal, Cem Meydan, Jonathan Foox, Christopher Mozsary, Bianca Cerqueira, Viktorija Zaksas, Urminder Singh, Eve Syrkin Wurtele, Sylvain Costes, Gustavo Gastao Davanzo, Diego Galeano, Alberto Paccanaro, Suzanne L. Meinig, Robert S. Hagan, Natalie M. Bowman, Matthew C. Wolfgang, Selin Altinok, Nicolae Sapoval, Todd J. Treangen, Pedro M. Moraes-Vieira, Charles Vanderburg, Douglas C. Wallace, Jonathan C. Schisler, Christopher E. Mason, Anushree Chatterjee, Robert Meller, Afshin Beheshti

Summary: The research demonstrates that miR-2392 is associated with SARS-CoV-2 infection, with potential for use in COVID-19 detection and as a target for antiviral therapy. Targeting miR-2392 can significantly reduce SARS-CoV-2 viability, indicating a potential treatment for COVID-19.

CELL REPORTS (2021)

Editorial Material Medicine, General & Internal

Single-Dose Ad26.COV2.S Vaccine-Room for Improvement

Zahra Rikhtegaran Tehrani, Mohammad M. Sajadi

JAMA NETWORK OPEN (2021)

Article Medicine, General & Internal

COVID-19 Infection Among Women in Iran Exposed vs Unexposed to Children Who Received Attenuated Poliovirus Used in Oral Polio Vaccine

Farrokh Habibzadeh, Mohammad M. Sajadi, Konstantin Chumakov, Mahboobeh Yadollahie, Shyamasundaran Kottilil, Ashraf Simi, Kristen Stafford, Saeid Saeidimehr, Mohammad Rafiei, Robert C. Gallo

Summary: A longitudinal cohort study in Iran found that indirect exposure to live attenuated poliovirus was associated with decreased symptomatic infection with COVID-19. Further studies on the potential protective effect of OPV should be conducted, especially in countries where specific COVID-19 vaccines are delayed or less affordable.

JAMA NETWORK OPEN (2021)

Article Microbiology

Mucosal and Systemic Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Determined by Severity of Primary Infection

Mohammad M. Sajadi, Amber Myers, James Logue, Saman Saadat, Narjes Shokatpour, James Quinn, Michelle Newman, Meagan Deming, Zahra Rikhtegaran Tehrani, Laurence S. Magder, Maryam Karimi, Abdolrahim Abbasi, Mike Shlyak, Lauren Baracco, Matthew B. Frieman, Shane Crotty, Anthony D. Harris

Summary: Understanding the immune responses to the SARS-CoV-2 spike protein is crucial in controlling the COVID-19 pandemic. This study examines the responses to SARS-CoV-2 mRNA vaccines in individuals with and without prior infection, revealing that the severity of infection impacts the IgA responses in primary infection and vaccination response (peak responses and durability), which has implications for protection against reinfection.

MSPHERE (2022)

Review Psychology, Multidisciplinary

COVID-19 and Integrated Multidisciplinary Care Model in Parkinson's Disease: Literature Review & Future Perspectives

Seyed-Mohammad Fereshtehnejad, Mayela Rodriguez-Violante, Monica S. Ponce-Rivera, Daniel Martinez-Ramirez, Adolfo Ramirez-Zamora

Summary: The diverse clinical manifestations of Parkinson's disease require the involvement of multiple healthcare professionals. The COVID-19 pandemic has posed challenges to implementing multidisciplinary care models, but innovative virtual platforms are being developed to address this issue.

BEHAVIORAL SCIENCES (2022)

Article Multidisciplinary Sciences

Maternal transfer of IgA and IgG SARS-CoV-2 specific antibodies transplacentally and via breast milk feeding

Mohammad M. Sajadi, Narjes Shokatpour, Madeleine Purcell, Zahra Rikhtegaran Tehrani, Allison Lankford, Allison Bathula, James D. Campbell, Elizabeth Adrianne Hammershaimb, Kristopher B. Deatrick, Casey Bor, Dawn M. Parsell, Colleen Dugan, Andrea R. Levine, Sabrina C. Ramelli, Daniel S. Chertow, Daniel L. Herr, Kapil K. Saharia, George K. Lewis, Alison Grazioli

Summary: This study investigated the fate of SARS-CoV-2 antibodies in breast milk in infants and whether they are delivered to immunologically relevant sites. The results showed that vaccination antepartum followed by breast milk feeding is the best way to provide systemic and local antibodies for infants. Breast milk fed infants only acquired antibodies if their mothers were vaccinated antepartum, highlighting the importance of maternal transfer of antibodies through breastfeeding.

PLOS ONE (2023)

Meeting Abstract Clinical Neurology

Can We Predict Long-Term MS Outcomes With A Blood Test?

S. Thebault, M. Abdoli, S. Fereshtehnejad, D. Tessier, V. Tabard-Cossa, M. S. Freedman

MULTIPLE SCLEROSIS JOURNAL (2020)

Article Virology

Hemagglutinin affects replication, stability and airborne transmission of the H9N2 subtype avian influenza virus

Naiqing Xu, Xinen Tang, Xin Wang, Miao Cai, Xiaowen Liu, Xiaolong Lu, Shunlin Hu, Min Gu, Jiao Hu, Ruyi Gao, Kaituo Liu, Yu Chen, Xiufan Liu, Xiaoquan Wang

Summary: This study found that the H9N2 subtype avian influenza virus has a high airborne transmissibility, while the H7N9 virus does not. The Hemagglutinin protein of the H9N2 virus was found to play a key role in replication, stability, and airborne transmission.

VIROLOGY (2024)

Article Virology

Contagious ecthyma in Egypt: Clinical, virological and molecular explorations

Samar S. Ewies, Sabry M. Tamam, Ahmed S. Abdel-Moneim, Sherin R. Rouby

Summary: Contagious ecthyma (CE) is a highly contagious viral disease of sheep and goats worldwide. The study provided a clinical description of CE and screened for genetic variation in the B2L gene. Infected sheep exhibited anorexia and oral lesions, while inoculated chicken embryos showed pock lesions. The B2L gene was successfully amplified and found to be highly conserved.

VIROLOGY (2024)

Article Virology

Genetic characterization of newly emerging avian reovirus variants in chickens with viral arthritis/tenosynovitis in Israel

Yigal Farnoushi, Dan Heller, Avishai Lublin

Summary: In recent years, new variants of avian reovirus (ARV) have caused a variety of symptoms in chickens worldwide, including viral arthritis/tenosynovitis. This study analyzed emerging ARV variants in Israel and found significant genetic diversity. Most ARV isolates in Israel belonged to genotypic cluster 5 (GC5). The study suggests that Israel has not experienced the emergence of new ARV variants since the introduction of the live vaccine (ISR-7585), but ongoing monitoring is needed due to the continuous emergence of ARV variants.

VIROLOGY (2024)

Article Virology

Mutations in the 3′ non-coding region of a no-known vector flavivirus Yokose virus increased its replication ability in mosquito C6/36 cells

Shigeru Tajima, Michiyo Kataoka, Yuki Takamatsu, Hideki Ebihara, Chang-Kweng Lim

Summary: Yokose virus (YOKV), a bat-associated flavivirus, was found to replicate at a slower rate in mosquito cells compared to other mosquito-borne flaviviruses. Specific nucleotide mutations in the virus were identified to enhance its proliferation ability in mosquito cells.

VIROLOGY (2024)

Article Virology

Innate immune responses reverse HIV cognitive disease in mice: Profile by RNAseq in the brain

Alejandra Borjabad, Baojun Dong, Wei Chao, David J. Volsky, Mary Jane Potash

Summary: This study investigated HIV brain disease using a mouse model, and found that poly I:C can reverse associated cognitive impairment and reduce virus burden. The results also revealed transcriptional changes related to neuronal function and innate immune responses.

VIROLOGY (2024)

Article Virology

Identification of subgenomic mRNAs derived from the coronavirus 1a/1b protein gene: Implications for coronavirus transcription

Ching-Hung Lin, Feng-Cheng Hsieh, Meilin Wang, Chieh Hsu, Hsuan-Wei Hsu, Chun-Chun Yang, Cheng-Yao Yang, Hung-Yi Wu

Summary: This study demonstrates that the synthesis of coronavirus subgenomic mRNA is not solely determined by the sequence homology between the leader TRS and TRS-B, but also by the disassociation of the coronavirus polymerase from the viral genome. This finding provides a new insight into the transcription mechanism of coronaviruses.

VIROLOGY (2024)

Article Virology

Expression dynamics of the aplysia abyssovirus

Nicholas S. Kron, Benjamin W. Neuman, Sathish Kumar, Patricia L. Blackwelder, Dayana Vidal, Delphina Z. Walker-Phelan, Patrick D. I. Gibbs, Lynne A. Fieber, Michael C. Schmale

Summary: Two recent studies documented the genome of a novel virus in marine animals, finding that the virus is widespread in apparently healthy animals but not highly expressed in neurons. The studies also identified viral replication factories and high levels of defective genomes in chronically infected animals.

VIROLOGY (2024)

Article Virology

Molecular detection and characterization of highly pathogenic H5N1 clade 2.3.4.4b avian influenza viruses among hunter-harvested wild birds provides evidence for three independent introductions into Alaska

Andrew M. Ramey, Laura C. Scott, Christina A. Ahlstrom, Evan J. Buck, Alison R. Williams, Mia Kim Torchetti, David E. Stallknecht, Rebecca L. Poulson

Summary: We successfully detected and characterized highly pathogenic avian influenza viruses in hunter-harvested wild waterfowl samples from western Alaska. Genomic analysis revealed three independent viral introductions into Alaska. Our findings demonstrate the utility and potential limitations of using molecular processing approaches directly on original swab samples for viral research and monitoring.

VIROLOGY (2024)

Article Virology

Inhibitory effects of quercetin on porcine epidemic diarrhea virus in vitro and in vivo

Ting Gong, Dongdong Wu, Yongzhi Feng, Xing Liu, Qi Gao, Xiaoyu Zheng, Zebu Song, Heng Wang, Guihong Zhang, Lang Gong

Summary: This study discovered that quercetin can inhibit PEDV replication both in vivo and in vitro, and alleviate the clinical symptoms and intestinal injury caused by the virus. This provides a new direction for the development of PED antiviral drugs.

VIROLOGY (2024)

Article Virology

Reassortant H9N2 canine influenza viruses containing the pandemic H1N1/ 2009 ribonucleoprotein complex circulating in pigs acquired enhanced virulence in mice

Min Zhu, Hao Zeng, Jianqiao He, Yaohui Zhu, Pingping Wang, Jianing Guo, Jinfan Guo, Huabo Zhou, Yifeng Qin, Kang Ouyang, Zuzhang Wei, Weijian Huang, Ying Chen

Summary: The reassortment between avian H9N2 and Eurasian avian-like (EA) H1N1 viruses may have potentially changed from avian-to-mammals adaptation. This study found that the introduction of EA H1N1 internal genes into H9N2 virus restored the replication capability and resulted in extreme virulence in some cases. This raises new concerns for public health due to the possible coexistence of H9N2 and EA H1N1 viruses in dogs.

VIROLOGY (2024)